Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial"

Circulation. 2011 Apr 12;123(14):e404; author reply e405. doi: 10.1161/CIRCULATIONAHA.110.985093.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Acetanilides / therapeutic use
  • Acute Coronary Syndrome / complications*
  • Acute Coronary Syndrome / drug therapy
  • Acute Coronary Syndrome / physiopathology*
  • Amiodarone / therapeutic use
  • Anti-Arrhythmia Agents / therapeutic use
  • Death, Sudden, Cardiac / epidemiology*
  • Electrocardiography
  • Enzyme Inhibitors / therapeutic use
  • Heart Rate / physiology
  • Humans
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / physiopathology
  • Myocardial Ischemia / drug therapy
  • Piperazines / therapeutic use
  • Predictive Value of Tests
  • Ranolazine
  • Risk Factors
  • Stroke Volume / physiology
  • Tachycardia, Ventricular / drug therapy
  • Tachycardia, Ventricular / etiology*
  • Tachycardia, Ventricular / physiopathology*
  • Thrombolytic Therapy

Substances

  • Acetanilides
  • Anti-Arrhythmia Agents
  • Enzyme Inhibitors
  • Piperazines
  • Ranolazine
  • Amiodarone